Prolight Diagnostics
0.20 SEK
+3.70 %
Less than 1K followers
PRLD
Nordic SME
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+3.70 %
+15.29 %
-18.33 %
-17.00 %
+59.80 %
+45.67 %
-12.60 %
-89.01 %
-50.20 %
Prolight Diagnostics develops point-of-care (POC) systems. These are small mobile instruments with disposable test cards that can perform In-Vitro Diagnostic (IVD) tests from a drop of blood. The POC system can contribute to faster and more accurate diagnoses of acute conditions. The company's launch product will be a highly sensitive measurement of troponin to be able to determine and exclude heart attacks.
Read moreMarket cap
236.08M SEK
Turnover
402.1K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2
2026
Annual report '25
26.5
2026
Interim report Q1'26
26.5
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
Prolight announces timetable for share reverse split
Prolight Diagnostics publishes quarterly report Q3, 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools